About
Technology
Issues
FAQ
Links
Official Page
Continuous long-term immunomodulatory therapy in relapsing multiple sclerosis: results from the 15-year analysis of the US prospective open-label study of glatiramer acetate
Distribution of the number of citations over years.
site/software ©
exaly
; All materials licenced under
CC by-SA
.